Tight Control in Type 2 Diabetes: More Harm than Good?
This module discusses why tight control may not be the best strategy for treating type 2 diabetes, reveals surprising facts about the benefits and harms of current treatments and strategies for diabetes care, and provides practical advice for counseling patients about healthful eating patterns and increasing physical activity.
This activity is intended for physicians, nurses, pharmacists, and other healthcare professionals.
Upon completion of this module, the learner should be able to:
- Discuss the risks and benefits of metformin, insulin, and other treatments for type 2 diabetes.
- Describe the limitations of clinical evidence regarding tight control in patients with type 2 diabetes.
- Implement new strategies for counseling patients about making lifestyle changes.
The material presented in this continuing medical education program is being made available for educational purposes and does not reflect the official views or policies of the DC Department of Health unless explicitly stated.
Thomas Finucane, MD
Gerontology Co-Director, Elder House Call Program JHBMC
John Hopkins University School of Medicine
Adriane Fugh-Berman, MD
Department of Family Medicine
Georgetown University Medical Center
Stephen Lippman, MD, PhD
Kofi Onumah, PharmD, RPh
Director, The DC Center for Rational Prescribing
District of Columbia Department of Health
Leonard Pogach, MD, MBA
Veterans Health Administration
Caroline Trapp, DNP, ANP-BC, CDE, FAANP
Physicians Committee for Responsible Medicine
Susan F. Wood, PhD
Director, Jacobs Institute of Women's Health
The George Washington University Milken Institute School of Public Health
- Kofi Onumah, PharmD, RPh
- Leonard Pogach, MD, MBA
- Caroline Trapp, DNP, ANP-BC, FAANP
- Susan F. Wood, PhD
- Dr. Tom Finucane is a member of the Pharmacy and Therapeutics Committee for Anthem Inc.
- Dr. Adriane Fugh-Berman discloses that she is a paid expert witness at the request of plaintiffs in litigation regarding pharmaceutical marketing practices. She is also a subcontractor to George Washington School of Public Health.
- Dr. Stephen Lippman discloses that he has been a paid expert witness at the request of plaintiffs in litigation regarding pharmaceutical marketing practices.
PHARMACISTS AND PHARMACY TECHNICIANS
- 1.50 ACPE PharmacistThe George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.50 ACPE Pharmacy technicianThe George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
- 1.50 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.50 Completion
High-speed internet connection
- This educational activity has been tested in the latest versions of Internet Explorer, Edge, Firefox, Safari, and Chrome browsers on Windows or Macintosh computers.
- The Safari, Firefox, or Chrome browsers are recommended for best results.
- The Internet Explorer browser is not recommended. If you must use Internet Explorer, please update to version 11, which is the only version supported by Microsoft at this writing.